PIC/S agrees to share with WHO, adds members, mulls FDA application
This article was originally published in The Gold Sheet
The Pharmaceutical Inspection Cooperation Scheme May 27 reached agreement with the World Health Organization's team for quality assurance and safety and its team for biologicals and medicines on an agreement to cooperate in the areas of training inspectors and sharing documents. The international group of pharmaceutical inspection agencies has grown from its core in Europe to include agencies from 37 countries around the world including Lithuania, which joined this month. Iran has asked to join, and there are signs of interest from Japan, Brazil, Russia and New Zealand. According to the minutes, there was talk at its latest meeting in early May of establishing a second-tier category for inspection authorities in countries such as India and China that are not yet competent enough for full membership. Meanwhile, FDA's application to join is still pending, with an audit of the agency expected later this year
You may also be interested in...
A trio of newly finalized guidance documents from the US agency dated 25 September explain how the Accreditation Scheme for Conformity Assessment pilot will work, and what biocompatibility and safety standards will apply.
Approval of Alaway Preservative Free (ketotifen fumarate, 0.035) comes 15 months after FDA submitted a complete response letter to Bausch and the active ingredient developer, Eton Pharmaceuticals.
Unfounded expectation some firms have for FDA to protect their investments in preparing successful NDI notifications is part of industry’s overall interest in increased regulation of the market, says Steven Tave, Office of Dietary Supplement Programs director.